Stephen C. Cosenza

2.4k total citations
55 papers, 2.0k citations indexed

About

Stephen C. Cosenza is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Stephen C. Cosenza has authored 55 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 26 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Stephen C. Cosenza's work include Cancer-related Molecular Pathways (12 papers), Microtubule and mitosis dynamics (8 papers) and Advanced Breast Cancer Therapies (8 papers). Stephen C. Cosenza is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Microtubule and mitosis dynamics (8 papers) and Advanced Breast Cancer Therapies (8 papers). Stephen C. Cosenza collaborates with scholars based in United States and Spain. Stephen C. Cosenza's co-authors include E. Premkumar Reddy, M. V. Ramana Reddy, Kiranmai Gumireddy, Stacey J. Baker, Muralidhar R. Mallireddigari, Kenneth J. Soprano, Kimberly A. Robell, Thomas A. Owen, J. G. Holland and Venkat R. Pallela and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Stephen C. Cosenza

55 papers receiving 1.9k citations

Peers

Countries citing papers authored by Stephen C. Cosenza

Since Specialization

Citations

This map shows the geographic impact of Stephen C. Cosenza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Cosenza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Cosenza more than expected).

Fields of papers citing papers by Stephen C. Cosenza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Cosenza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Cosenza. The network helps show where Stephen C. Cosenza may publish in the future.

Co-authorship network of co-authors of Stephen C. Cosenza

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Cosenza. A scholar is included among the top collaborators of Stephen C. Cosenza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. Cosenza. Stephen C. Cosenza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prolonged cell cycle arrest by the CDK4/6 antagonist narazaciclib restores ibrutinib response in preclinical models of BTKi‐resistant mantle cell lymphoma 2023 ·Hematological Oncology ·(unknown), Marcelo Lima Ribeiro, (unknown), (unknown), (unknown), (unknown), Stephen C. Cosenza, Manel Esteller, Gaël Roué	3
2	Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease 2021 ·Nature Communications ·Katsutoshi Sato, (unknown), Stacey J. Baker, Stephen C. Cosenza, Olga Rechkoblit, (unknown), Josep Domingo‐Domenech, (unknown), Elisa Port, Aneel K. Aggarwal, M. V. Ramana Reddy, Hanna Y. Irie, E. Premkumar Reddy	46
3	A Contaminant Impurity, Not Rigosertib, Is a Tubulin Binding Agent 2020 ·Molecular Cell ·Stacey J. Baker, Stephen C. Cosenza, Sai Krishna Athaluri Divakar, M. V. Ramana Reddy, Rodrigo Vasquez‐Del Carpio, Rinku Jain, Aneel K. Aggarwal, E. Premkumar Reddy	12
4	A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling 2016 ·Cell ·Sai Krishna Athaluri Divakar, Rodrigo Vasquez‐Del Carpio, Kaushik Dutta, Stacey J. Baker, Stephen C. Cosenza, Indranil Basu, Yogesh K. Gupta, M. V. Ramana Reddy, Lynn Ueno, Jonathan R. Hart, Peter K. Vogt, David J. Mulholland, Chandan Guha, Aneel K. Aggarwal, E. Premkumar Reddy	205
5	Dual inhibition of CDK4/Rb and PI3K/AKT/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas 2015 ·Leukemia ·Sai Krishna Athaluri Divakar, M. V. Ramana Reddy, Stephen C. Cosenza, Stacey J. Baker, (unknown), (unknown), Jonathan R. Brody, (unknown), Samir Parekh, E. Premkumar Reddy	24
6	Preclinical Pharmacokinetic and Pharmacodynamic Evaluation of Novel Anticancer Agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for Brain Tumor Chemotherapy 2012 ·Pharmaceutical Research ·Silpa Nuthalapati, Qingyu Zhou, Ping Guo, Hua Lv, Stephen C. Cosenza, M. V. Ramana Reddy, E. Premkumar Reddy, James M. Gallo	12
7	Determination of the glucuronide metabolite of ON 013100, a benzylstyrylsulfone antineoplastic drug, in colon cancer cells using LC/MS/MS 2012 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Stephen C. Cosenza, Venkat R. Pallela, (unknown), M. V. Ramana Reddy, E. Premkumar Reddy, John Roboz	2
8	A Non-ATP-Competitive Dual Inhibitor of JAK2V617F and BCR-ABLT315I Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition 2010 ·Genes & Cancer ·Shashi Jatiani, Stephen C. Cosenza, M. V. Ramana Reddy, Ji Hee Ha, Suzanne J. Baker, Abhishek Samanta, Matthew J. Olnes, Loretta Pfannes, Elaine M. Sloand, Ralph B. Arlinghaus, E. Premkumar Reddy	27
9	Design, synthesis and evaluation of (E)-α-benzylthio chalcones as novel inhibitors of BCR-ABL kinase 2010 ·Bioorganic & Medicinal Chemistry ·M. V. Ramana Reddy, Venkat R. Pallela, Stephen C. Cosenza, Muralidhar R. Mallireddigari, (unknown), (unknown), May Truongcao, (unknown), Shashi Jatiani, E. Premkumar Reddy	22
10	Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent 2009 ·Cancer Chemotherapy and Pharmacology ·(unknown), Stephen C. Cosenza, David R. Taft, Manoj Maniar	24
11	Differences in binding of 99mTc-disintegrins to integrin αvβ3 on tumor and vascular cells 2007 ·Nuclear Medicine and Biology ·Linda Knight, Jan E. Romano, Stephen C. Cosenza, (unknown), Cezary Marcinkiewicz	6
12	A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance 2005 ·Proceedings of the National Academy of Sciences ·Kiranmai Gumireddy, Stacey J. Baker, Stephen C. Cosenza, (unknown), Anthony D. Kang, Kimberly A. Robell, M. V. Ramana Reddy, E. Premkumar Reddy	172
13	ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent 2005 ·Cancer Cell ·Kiranmai Gumireddy, M. V. Ramana Reddy, Stephen C. Cosenza, (unknown), Stacey J. Baker, (unknown), Jian‐Dong Jiang, J. G. Holland, E. Premkumar Reddy	303
14	Radiation damage protection by the benzyl styrl sulfone analog, ex-rad 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Amauri Alcindo Alfieri, (unknown), Anand Sharma, Giridhar R. Gorla, Stanley C. Bell, (unknown), Stephen C. Cosenza, (unknown), C. Guha	3
15	Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Muralidhar R. Mallireddigari, Stephen C. Cosenza, Kiranmai Gumireddy, Stanley C. Bell, E. Premkumar Reddy, M. V. Ramana Reddy	153
16	The Role of v-Fgr Myristoylation and the Gag Domain in Membrane Binding and Cellular Transformation 1998 ·Virology ·Stacey J. Baker, Stephen C. Cosenza, E. Premkumar Reddy	3
17	Scintigraphic imaging of oncogenes with antisense probes: does it make sense? 1995 ·European Journal of Nuclear Medicine and Molecular Imaging ·J.L. Urbain, Scott K. Shore, Marcel Vekemans, Stephen C. Cosenza, (unknown), (unknown), N. David Charkes, L.S. Malmud, (unknown)	23
18	Induction of c‐fos and c‐jun mRNA at the M/G₁ border is required for cell cycle progression 1994 ·Journal of Cellular Biochemistry ·Stephen C. Cosenza, Gladys Yumet, Dianne Robert Soprano, Kenneth J. Soprano	20
19	Growth‐associated gene expression is not constant in cells traversing G‐1 after exiting mitosis 1991 ·Journal of Cellular Physiology ·Stephen C. Cosenza, Ruth Carter, (unknown), (unknown), Michael J. Borrelli, Dianne Robert Soprano, Kenneth J. Soprano	8
20	Normalization of multiple RNA samples using an in vitro-synthesized external standard cRNA 1987 ·Analytical Biochemistry ·A Toscani, Dianne Robert Soprano, Stephen C. Cosenza, Thomas A. Owen, Kenneth J. Soprano	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact